Quantitative histological image analyses of reticulin fibers in a myelofibrotic mouse
1. Vardiman, J.W., et al., The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 2009. 114(5): p. 937-51.
2. Tefferi, A. and W. Vainchenker, Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol, 2011. 29(5): p. 573-82.
3. James, C., et al., A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 2005. 434(7037): p. 1144-8.
4. Kralovics, R., et al., A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med, 2005. 352(17): p. 1779-90.
5. Zhao, R., et al., Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem, 2005. 280(24): p. 22788-92.
6. Vannucchi, A.M., et al., Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. Am J Pathol, 2005. 167(3): p. 849-58.
7. Achison, M., et al., Integrin-independent tyrosine phosphorylation of p125(fak) in human platelets stimulated by collagen. J Biol Chem, 2001. 276(5): p. 3167-74.
8. Mullally, A., et al., Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells. Cancer Cell, 2010. 17(6): p. 584-96.
9. Hobbs, C.M., et al., JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia. Blood, 2013. 122(23): p. 3787-97.
10. Vannucchi, A.M., et al., Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood, 2002. 100(4): p. 1123-32.
11. Gomori, G., Silver Impregnation of Reticulum in Paraffin Sections. Am J Pathol, 1937. 13(6): p. 993-1002 5.
12. Kuter, D.J., et al., Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol, 2007. 139(3): p. 351-62.
13. Vener, C., et al., Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis. Blood, 2008. 111(4): p. 1862-5.
14. Teman, C.J., et al., Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study. Leuk Res, 2010. 34(7): p. 871-6.
15. Kvasnicka, H.M., et al., Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study. Histopathology, 2016. 68(6): p. 905-15.
16. Martelli, F., et al., Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds. Blood, 2005. 106(13): p. 4102-13.
17. McDevitt, M.A., et al., A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A, 1997. 94(13): p. 6781-5.
18. Muntean, A.G., et al., Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood, 2007. 109(12): p. 5199-207.
19. Eliades, A., et al., Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J Biol Chem, 2011. 286(31): p. 27630-8.
20. Schneider, C.A., W.S. Rasband, and K.W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis. Nat Methods, 2012. 9(7): p. 671-5.
21. Hyter, A.J., A Proof of the Conjecture that the Tukey-Kramer Multiple Comparisons Procedure is Conservative. The Annals of Statistics, 1984. 12: p. 61-75.
22. Prasad, K. and G.K. Prabhu, Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research-a review. J Med Syst, 2012. 36(4): p. 2621-31.
23. Wagner, T. and H.G. Lipinski, IJBlob: An ImageJ Library for Connected Component Analysis and Shape Analysis. Journal of Open Research Software, 2013. 1: p. e6.
24. Thiele, J., et al., Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy)--a morphometric evaluation before and after therapy. Virchows Arch A Pathol Anat Histopathol, 1990. 417(6): p. 485-92.
25. Zingariello, M., et al., Characterization of the TGF-beta1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood, 2013. 121(17): p. 3345-63.
26. Zetterberg, E., et al., Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows. Haematologica, 2007. 92(5): p. 597-604.
27. Thiele, J., et al., European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica, 2005. 90(8): p. 1128-32.